0A4F4F9BD490A749D5437F821CF06DF1
Health Research with Consent (2018)
https://www.cnil.fr/fr/declaration/mr-001-recherches-dans-le-domaine-de-la-sante-avec-recueil-du-consentement
http://leaux.net/URLS/ConvertAPI Text Files/427974E49F122F20B87E0176EECEF6C1.en.txt
Examining the file media/Synopses/427974E49F122F20B87E0176EECEF6C1.html:
This file was generated: 2020-07-14 08:33:55
| Indicators in focus are typically shown highlighted in yellow; |
Peer Indicators (that share the same Vulnerability association) are shown highlighted in pink; |
"Outside" Indicators (those that do NOT share the same Vulnerability association) are shown highlighted in green; |
Trigger Words/Phrases are shown highlighted in gray. |
Link to Orphaned Trigger Words (Appendix (Indicator List, Indicator Peers, Trigger Words, Type/Vulnerability/Indicator Overlay)
Applicable Type / Vulnerability / Indicator Overlay for this Input
| Vulnerability Type | Vulnerability | Indicator | # Matches |
|---|
| Health | Drug Usage | drug | 1 |
Health / Drug Usage
Searching for indicator drug:
(return to top)
p.(None): Individual Professional
p.(None): MY STEPS
p.(None): THEMES
p.(None): TECHNOLOGIES
p.(None): OFFICIAL TEXTS
p.(None): THE CNIL
p.(None): MY COMPLIANCE WITH THE GDPR
p.(None): THEMES
p.(None): TECHNOLOGIES
p.(None): OFFICIAL TEXTS
p.(None): THE CNIL
p.(None): NEED HELP ?
p.(None): FR | EN
p.(None): > Declare a file> Research in the health field with consent collection My selection
p.(None): Reference methodology MR-001
p.(None): Health research with consent
p.(None): The MR-001 reference methodology frames the treatments including
p.(None): health and of a public interest nature, carried out as part of research
p.(None): requiring the consent of the data subject or that of their representatives
p.(None): legal. It is specified that the consent mentioned in the reference methodology is relative
p.(None): participating in patient research and / or agreeing to perform an examination
p.(None): genetic characteristics, not the legal basis for processing within the meaning of the GDPR. It's about
p.(None): more specifically interventional research, including risky research and
p.(None): minimal constraints, clinical drug trials and research requiring
p.(None): carrying out an examination of genetic characteristics. Individual patient information
p.(None): is obligatory. The data controller undertakes to collect only the data
p.(None): strictly necessary and relevant to the research objectives.
p.(None): OFFICIAL TEXT
p.(None): Deliberation n ° 2018-153 of May 3, 2018
p.(None): Data controllers concerned
p.(None): Objective (s) pursued by the processing (purposes)
p.(None): Personal data concerned
p.(None): Data excluded from the scope of the standard
p.(None): Data retention period
p.(None): Data recipients
p.(None): Information for people and respect for IT and
p.(None): freedoms "
p.(None): Security and confidentiality
p.(None): Data transfers outside the European Union
p.(None): Download PDF Add to my selection
p.(None): Return
p.(None): Your study does not fall within the framework of this reference methodology
p.(None): ?
p.(None): You must make a request for authorization - research with the CNIL
p.(None): Authorization form - research
p.(None): Subscribe to the newsletter
p.(None): nom@example.fr SUBSCRIBE TO THE NEWSLETTER
p.(None): Your email address is only used to send you CNIL newsletters. You can use the link at any time
p.(None): unsubscribe integrated into the newsletter. Learn more about managing your data and your rights
p.(None): Follow us
p.(None): MEDIA
p.(None): GLOSSARY
p.(None): FR-EN LEXICON
p.(None): NEED HELP
p.(None): HURRY
p.(None): FR | EN
p.(None): COOKIES MANAGEMENT
...
Orphaned Trigger Words
Appendix
Indicator List
| Indicator | Vulnerability |
|---|
| drug | Drug Usage |
Indicator Peers (Indicators in Same Vulnerability)
Trigger Words
consent
Applicable Type / Vulnerability / Indicator Overlay for this Input
| Vulnerability Type | Vulnerability | Indicator | # Matches |
|---|
| Health | Drug Usage | drug | 1 |